Literature DB >> 11581576

Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol.

K Kawasaki1, S Akashi, R Shimazu, T Yoshida, K Miyake, M Nishijima.   

Abstract

Taxol, an antitumor agent derived from a plant, mimics the action of lipopolysaccharide (LPS) in mice, but not in humans. The LPS-mimetic activity of Taxol is not observed in LPS-hyporesponsive C3H/HeJ mice which possess a point mutation in Toll-like receptor 4 (TLR4); therefore, TLR4 appears to be involved in both Taxol and LPS signaling. In addition, TLR4 was recently shown to physically associate with MD-2, a molecule that confers LPS-responsiveness on TLR4. Here we examined whether or not TLR4/MD-2 complex mediates a Taxol-induced signal by using transformants of the mouse pro-B cell line, Ba/F3, expressing mouse TLR4 alone, both mouse TLR4 and mouse MD-2, and both mouse MD-2 and mouse TLR4 lacking the cytoplasmic portion. Our results demonstrated that co-expression of mouse TLR4 and mouse MD-2 was required for Taxol responsiveness, and that the TLR4/MD-2 complex is the shared molecule in Taxol and LPS signal transduction in mice. We also found that mouse MD-2, but not human MD-2, is involved in Taxol signaling, suggesting that MD-2 is responsible for the species-specific responsiveness to Taxol.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581576

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  18 in total

1.  Radioiodination of an endotoxin·MD-2 complex generates a novel sensitive, high-affinity ligand for TLR4.

Authors:  Athmane Teghanemt; Jerrold P Weiss; Theresa L Gioannini
Journal:  Innate Immun       Date:  2013-02-25       Impact factor: 2.680

2.  Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.

Authors:  A Deguchi; T Tomita; U Ohto; K Takemura; A Kitao; S Akashi-Takamura; K Miyake; Y Maru
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

3.  Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.

Authors:  Mohamed Naguib; Jijun J Xu; Philippe Diaz; David L Brown; David Cogdell; Bihua Bie; Jianhua Hu; Suzanne Craig; Walter N Hittelman
Journal:  Anesth Analg       Date:  2012-03-05       Impact factor: 5.108

4.  Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro.

Authors:  Pankajini Mallick; Sumit Basu; Bhagavtula Moorthy; Romi Ghose
Journal:  Toxicol In Vitro       Date:  2017-02-27       Impact factor: 3.500

5.  Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies.

Authors:  Marie Duhamel; Mélanie Rose; Franck Rodet; Adriana Natalia Murgoci; Lea Zografidou; Anne Régnier-Vigouroux; Fabien Vanden Abeele; Firas Kobeissy; Serge Nataf; Laurent Pays; Maxence Wisztorski; Dasa Cizkova; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2018-03-12       Impact factor: 5.911

6.  Development of a mouse model for assessing fatigue during chemotherapy.

Authors:  Maria A Ray; Rita A Trammell; Steve Verhulst; Sophia Ran; Linda A Toth
Journal:  Comp Med       Date:  2011-04       Impact factor: 0.982

7.  The role of disulfide bonds in the assembly and function of MD-2.

Authors:  Gregory E D Mullen; Margaret N Kennedy; Alberto Visintin; Alessandra Mazzoni; Cynthia A Leifer; David R Davies; David M Segal
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

8.  Novel roles of lysines 122, 125, and 58 in functional differences between human and murine MD-2.

Authors:  Jozica Vasl; Alja Oblak; Theresa L Gioannini; Jerrold P Weiss; Roman Jerala
Journal:  J Immunol       Date:  2009-09-25       Impact factor: 5.422

9.  Paclitaxel ameliorates lipopolysaccharide-induced kidney injury by binding myeloid differentiation protein-2 to block Toll-like receptor 4-mediated nuclear factor-κB activation and cytokine production.

Authors:  Dongshan Zhang; Yijian Li; Yu Liu; Xudong Xiang; Zheng Dong
Journal:  J Pharmacol Exp Ther       Date:  2013-01-14       Impact factor: 4.030

10.  TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.

Authors:  M Szajnik; M J Szczepanski; M Czystowska; E Elishaev; M Mandapathil; E Nowak-Markwitz; M Spaczynski; T L Whiteside
Journal:  Oncogene       Date:  2009-12-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.